Literature DB >> 2652730

Infections in pediatric liver recipients treated for acute rejection.

B Koneru1, V P Scantlebury, L Makowka, C O Esquivel, S Todo, A G Tzakis, J W Marsh, S Iwatsuki, L Douglas, T E Starzl.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2652730      PMCID： PMC2903875     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

1.  Hepatic Retransplantation.

Authors:  B W Shaw; R D Gordon; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1985-02       Impact factor: 1.066

2.  Impact of Orthoclone OKT3 on liver transplantation.

Authors:  J J Fung; B H Markus; R D Gordon; C O Esquivel; L Makowka; A Tzakis; T E Starzl
Journal:  Transplant Proc       Date:  1987-04       Impact factor: 1.066

3.  Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection.

Authors:  E M Gilbert; C C Eiswirth; D G Renlund; R L Menlove; C W DeWitt; L A Freedman; C M Herrick; W A Gay; M R Bristow
Journal:  Transplant Proc       Date:  1987-04       Impact factor: 1.066

4.  Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation.

Authors:  M K Breinig; B Zitelli; T E Starzl; M Ho
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

5.  A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants.

Authors: 
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

6.  Fungal infections in liver transplant recipients.

Authors:  C P Wajszczuk; J S Dummer; M Ho; D H Van Thiel; T E Starzl; S Iwatsuki; B Shaw
Journal:  Transplantation       Date:  1985-10       Impact factor: 4.939

7.  Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation.

Authors:  C S Oh; R J Stratta; B C Fox; H W Sollinger; F O Belzer; D G Maki
Journal:  Transplantation       Date:  1988-01       Impact factor: 4.939

Review 8.  Monoclonal antibody treatment of human allograft recipients.

Authors:  F L Delmonico; A B Cosimi
Journal:  Surg Gynecol Obstet       Date:  1988-01

9.  Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.

Authors:  N Singh; J S Dummer; S Kusne; M K Breinig; J A Armstrong; L Makowka; T E Starzl; M Ho
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226
  9 in total
  1 in total

1.  OKT3 and viral disease in pediatric liver transplant recipients.

Authors:  James S Bowman; Michael Green; Velma P Scantlebury; Saturo Todo; Andreas Tzakis; Shunzaburo Iwatsuki; Laura Douglas; Thomas E Starzl
Journal:  Clin Transplant       Date:  1991-08       Impact factor: 2.863
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.